收费全文 | 4484篇 |
免费 | 243篇 |
国内免费 | 18篇 |
耳鼻咽喉 | 84篇 |
儿科学 | 141篇 |
妇产科学 | 151篇 |
基础医学 | 484篇 |
口腔科学 | 110篇 |
临床医学 | 317篇 |
内科学 | 994篇 |
皮肤病学 | 87篇 |
神经病学 | 202篇 |
特种医学 | 75篇 |
外科学 | 868篇 |
综合类 | 119篇 |
一般理论 | 2篇 |
预防医学 | 335篇 |
眼科学 | 135篇 |
药学 | 376篇 |
中国医学 | 28篇 |
肿瘤学 | 237篇 |
2023年 | 60篇 |
2022年 | 139篇 |
2021年 | 209篇 |
2020年 | 125篇 |
2019年 | 151篇 |
2018年 | 212篇 |
2017年 | 118篇 |
2016年 | 139篇 |
2015年 | 168篇 |
2014年 | 173篇 |
2013年 | 233篇 |
2012年 | 381篇 |
2011年 | 373篇 |
2010年 | 192篇 |
2009年 | 144篇 |
2008年 | 244篇 |
2007年 | 237篇 |
2006年 | 218篇 |
2005年 | 221篇 |
2004年 | 180篇 |
2003年 | 173篇 |
2002年 | 151篇 |
2001年 | 43篇 |
2000年 | 34篇 |
1999年 | 43篇 |
1998年 | 30篇 |
1997年 | 20篇 |
1996年 | 13篇 |
1995年 | 20篇 |
1994年 | 12篇 |
1993年 | 13篇 |
1992年 | 13篇 |
1991年 | 17篇 |
1990年 | 11篇 |
1989年 | 20篇 |
1988年 | 16篇 |
1987年 | 13篇 |
1986年 | 13篇 |
1985年 | 12篇 |
1984年 | 15篇 |
1983年 | 16篇 |
1982年 | 7篇 |
1981年 | 18篇 |
1980年 | 14篇 |
1977年 | 8篇 |
1976年 | 10篇 |
1972年 | 6篇 |
1969年 | 5篇 |
1966年 | 5篇 |
1963年 | 5篇 |
Background
Multiple myeloma (MM) is a hematologic malignancy of plasma cell origin. MM primarily affects bone marrow, but extramedullary sites can also be involved. Myelomatous pleural effusion (MPE) is an atypical and rare complication of MM. We aimed to systematically study the incidence and clinicopathologic profile of patients with MPE in a real-world setting.Patients and Methods
In this retrospective study, 415 consecutive patients with MM managed at a tertiary care center in North India during a study period of January 1, 2010 to December 31, 2015 were evaluated for MPE. The patients with MPE were analyzed for their clinical profile, diagnosis, treatment, and outcomes.Results
Of these 415 patients, 11 (2.65%) patients had MPE. The median age of the study population was 50 years with male preponderance. The majority of these patients had immunoglobin (Ig)G Kappa disease. All patients had higher than International Staging System stage I disease. MPE was a presenting feature at MM diagnosis in 45.45% (n = 5) of the patients, whereas the rest developed MPE during follow-up. MPE presented predominantly (81.8%) as a unilateral effusion. Concurrent extramedullary involvement at other site was seen in 45.45% (n = 5), with 3 (27%) patients having concurrent myelomatous ascites. Six of these were managed aggressively, whereas 5 patients opted for palliation. The outcomes were dismal (90.9% mortality), with a median survival of 2.47 months.Conclusion
MPE is a rare entity, and positive outcomes of therapy remain low with dismal prognosis. 相似文献Methods: Tumour and surrounding tissue were modeled by elliptical two- and three-dimensional computational phantoms having six different nanoparticle distributions. Nanoparticles were modeled as point heat sources having amplitude-dependent loss power. The total number of nanoparticles was fixed, and their spatial distribution and heat output were varied. Heat transfer was computed by solving the Pennes’ bioheat equation using finite element methods (FEM) with temperature-dependent blood perfusion. Local temperature was regulated using a proportional-integral-derivative (PID) controller. Tissue temperature, thermal dose and tissue damage were calculated. The required minimum thermal dose delivered to the tumor was kept constant, and heating power was adjusted for comparison of both the heating methods.
Results: Modulated power heating produced lower and more homogeneous temperature distributions than did constant power heating for all studied nanoparticle distributions. For a concentrated nanoparticle distribution, located off-center within the tumor, the maximum temperatures inside the tumor were 16% lower for modulated power heating when compared to constant power heating. This resulted in less damage to surrounding normal tissue. Modulated power heating reached target thermal doses up to nine-fold more rapidly when compared to constant power heating.
Conclusions: Controlling the temperature at the tumor-healthy tissue boundary by modulating the heating power of magnetic nanoparticles demonstrably compensates for a variable nanoparticle distribution to deliver effective treatment. 相似文献